US 9725520
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 9725520 (HER3 specific monoclonal antibodies for diagnostic and therapeutic use) held by The Board of Regents of the University of Texas System expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61K45/06, A61P